08 Sport Auto New Tires Alloy Wheels Cd Curise Aux on 2040-cars

Auto blog

Honda profit targets tumble in wake of Takata scandal

Takata's massive airbag inflator recall will likely do some damage to Honda's bottom line this year, according to the Japanese automaker's latest forecasts. The company will allocate 50 billion yen ($425 million) to fulfill costs related to the safety campaigns, Reuters indicates. The decision will reduce estimated operating profit by about 6.5 percent to 720 billion yen ($6.1 billion US) for the fiscal year ending March 31. In addition to lower profits, Honda also cut back its sales estimate for the year to 4.45 million vehicles from the previous 4.62 million, according to Reuters. This was largely due to lower-than-expected demand in Japan. "We are not seeing a big impact on sales in North America from the airbag issue," company vice president Tetsuo Iwamura (pictured above) told Reuters. The decreased forecasts come at the same time as the possibility of another death in a Honda vehicle from the Takata parts. According to Automotive News, a man in Florida died in a crash in his 2002 Accord, but investigators have not yet determined whether the inflator was the cause. However, the vehicle was included in a 2011 recall for the part and was not repaired. The family intends to file a lawsuit alleging the inflator ruptured, spraying metal shrapnel into the driver's neck. Reportedly, the owner was never notified of the recall. While the Takata inflator recall is affecting many companies with alleged links to at least five deaths and 139 injuries worldwide, Honda has it among the worst. Including vehicles covered under the previous regional repair campaign for the issue, the automaker needs to repair roughly 5.4 million vehicles just in the US. Honda has taken action by employing suppliers other than Takata to supply some of its replacement parts for the recall. The business is also reportedly switching airbag suppliers for the next-gen Accord and possibly the 2016 CR-V and Odyssey.

2015 Honda HR-V looks fit for the urban jungle

Honda has been teasing us with the looks of its Fit-based compact crossover for months. Now the production version, dubbed the HR-V in the US, has finally been unveiled - in photographic form, at any rate - at the 2014 New York Auto Show. The CUV will slot into the brand's range this winter, and at the moment the company is keeping mum on many details about the new model.
The HR-V looks almost identical to the Urban SUV Concept unveiled at the Detroit Auto Show. The concept wore some nifty LED headlights and bigger wheels, but the rest of the styling has carried over to production. The handsome CUV sports diamond-shaped headlights, and a center bar splits the grille into two tiers. It has the same swoosh down the side running to the C-pillar, but it appears slightly less pronounced than in Detroit. The rear door handles are also hidden in the back pillar.
The compact crossover rides on the same platform as the new Fit. That allows it to take full advantage of the compact's highly versatile interior. The HR-V comes with Honda's Magic Seat that allows the back row to fold flat into the floor when needed.

Honda Walking Assist Device begins US testing at Rehabilitation Institute of Chicago

For years, we've been wondering what implications Honda's Asimo robot could have in the real world, and now we're starting to get a sense of that. Honda announced that it will begin its first US clinical studies of the Walking Assist Device at the Rehabilitation Institute of Chicago in an effort to provided improved mobility for people who have suffered a stroke. While the automotive tie-in here is pretty weak, this is the first time we've heard about this device since it was unveiled back in 2008.
Weighing in at six pounds, Honda's device is fitted to the waist and legs of patients to make it easier to walk, and the 22.2-volt lithium-ion battery provides enough electricity for more than an hour of operation. According to Honda's press release, which is posted below, up to 80 percent of the almost 800,000 stroke victims each year (in the US alone) are afflicted with limited mobility, so a medical aid like this could have a big impact in the real world.